Philips invested EUR 1.7 billion in R&D in 2024, focusing heavily on informatics and AI, which constitute about half of its R&D investments. The company filed 1,231 European patent applications, the most of any Dutch company, and was included in the Clarivate Top 100 Global Innovators 2025. Philips aims to improve the health and well-being of 2.5 billion people by 2030, having already impacted nearly 2 billion in 2024. The company generated EUR 18 billion in sales in 2024 and employs approximately 67,800 people worldwide.
Key takeaways:
- Philips was the leading applicant in medical technology patent filings at the European Patent Office in 2024, with 594 applications.
- The company launched several AI-powered innovations in 2024, including the Azurion image-guided therapy system and FDA-cleared AI tools for cardiovascular imaging.
- Philips invested approximately EUR 1.7 billion in research and development in 2024, focusing on informatics and AI technologies.
- Philips aims to improve the health and well-being of 2.5 billion people by 2030, having already impacted nearly 2 billion in 2024.